Erwin Adams

Erwin Adams serves as a Professor in the Department of Pharmaceutical and Pharmacological Sciences at KU Leuven's Faculty of Pharmaceutical Sciences, leading the Pharmaceutical Analysis unit (ON2 Herestraat 49, room 09.4226). He holds key institutional roles including membership in the Faculty Council, Pharmaceutical Sciences Doctoral Committee, and Departmental Council, reflecting his active academic leadership within the university structure.

His research centers on Pharmaceutical Analysis with specialization in Separation Techniques (LC, GC, CE) and Method Development and Validation for drug quality control. Current work focuses on affordable analytical methods for antimicrobial/hypertensive medicines, fingerprinting of smoke/vape products and plant supplements to detect fraud, and sterilant residue analysis - often addressing resource-limited contexts like Tanzania. His methodology integrates advanced chromatographic and electrophoretic approaches for real-world pharmaceutical challenges.

Analysis of his 2025 publications reveals strong thematic continuity in analytical method optimization, particularly gas chromatography for residue analysis, liquid chromatography for antibiotic quality control, and capillary electrophoresis for bioactive compound screening (notably PTP1B inhibitors). Projects consistently target cost-effective solutions for global health applications, with significant emphasis on detecting adulteration in herbal products and optimizing antimicrobial therapy stability.

No scientific awards are documented in the provided institutional profile.

Adams actively supervises graduate research, including Nguyen, T.M T.'s 2025 PhD work on antimicrobial therapy optimization. He serves as promotor for 10+ active projects through 2028 - such as 'Development of affordable analytical methods for antimicrobial medicines' and 'Fingerprinting of Smoke and Vape Products' - often addressing global health gaps. His grant portfolio demonstrates strong industry and regulatory relevance, particularly in resource-constrained settings.

Based in the Pharmaceutical Analysis unit, his research operations involve close collaboration with Van Schepdael, A. and interdisciplinary teams focused on analytical instrumentation development. Current projects indicate ongoing expansion into novel separation techniques for bioactive compound screening and field-deployable quality control methods for essential medicines.